Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/7/2025

Buprenorphine Induction for Opioid Use Disorder

Pre-Induction Assessment

  • The American College of Emergency Physicians recommends using the Clinical Opiate Withdrawal Scale (COWS) to objectively assess withdrawal severity, with buprenorphine administration only when COWS score is >8 (moderate to severe withdrawal) 1, 2
  • The American Society of Addiction Medicine suggests that administering buprenorphine before adequate withdrawal can precipitate severe withdrawal symptoms due to buprenorphine's high binding affinity and partial agonist properties 1, 2

Standard Induction Protocol

  • The American Academy of Addiction Psychiatry recommends an initial dose of 4-8 mg sublingual buprenorphine based on withdrawal severity, with reassessment after 30-60 minutes and additional 2-4 mg doses at 2-hour intervals if withdrawal persists 1
  • The target total dose on Day 1 is 8 mg (range 4-8 mg depending on patient response), with a standard maintenance dose of 16 mg total on Day 2 and beyond 1

Management of Precipitated Withdrawal

  • The American College of Physicians recommends administering 2 mg buprenorphine every 1-2 hours as primary treatment for precipitated withdrawal, with a high-dose approach escalating rapidly to 20 mg total if needed for severe precipitated withdrawal 1
  • The American Society of Addiction Medicine suggests adjunctive symptomatic management, including clonidine or lofexidine for autonomic symptoms, promethazine or ondansetron for nausea/vomiting, loperamide for diarrhea, and benzodiazepines for anxiety and muscle cramps 1, 3

Discharge Planning

  • The American Academy of Family Physicians recommends prescribing buprenorphine/naloxone 16 mg sublingual daily for 3-7 days or until follow-up, with provision of take-home naloxone kit and overdose prevention education 1
  • The American College of Obstetricians and Gynecologists suggests offering hepatitis C and HIV screening, as well as reproductive health counseling 1

Special Populations and Considerations

  • The American Society of Addiction Medicine recommends considering continuing methadone rather than switching to buprenorphine for methadone-maintained patients, as methadone has similar effectiveness for withdrawal management and avoids precipitated withdrawal risk 1

REFERENCES

1

Medications for Managing Opioid Withdrawal [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Management of Severe Opioid Withdrawal Pain [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025